[Myoclonic dystonia].
Cassim F.
Rev Neurol (Paris). 2003 Oct;159(10 Pt 1):892-9.
Myoclonic dystonia.
Obeso JA, Rothwell JC, Lang AE, Marsden CD.
Neurology. 1983 Jul;33(7):825-30. doi: 10.1212/wnl.33.7.825.
Myoclonic dystonia.
Pueschel SM, Friedman JH, Shetty T.
Childs Nerv Syst. 1992 Mar;8(2):61-6. doi: 10.1007/BF00298440.
Myoclonus-dystonia syndrome.
Nardocci N.
Handb Clin Neurol. 2011;100:563-75. doi: 10.1016/B978-0-444-52014-2.00041-0.
Myoclonic dystonia (DYT11) responsive to lacosamide: a case report.
Salari M, Asadi S, Etemadifar M, Rezaee M.
Acta Neurol Belg. 2022 Dec;122(6):1631-1632. doi: 10.1007/s13760-021-01756-5. Epub 2021 Jul 17.
Essential myoclonus and myoclonic dystonia.
Quinn NP.
Mov Disord. 1996 Mar;11(2):119-24. doi: 10.1002/mds.870110202.
Correction to: Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.
Dzinovic I, Serranová T, Prouteau C, Colin E, Ziegler A, Winkelmann J, Jech R, Zech M.
Neurogenetics. 2022 Jan;23(1):77. doi: 10.1007/s10048-021-00641-w.
Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.
Dzinovic I, Serranová T, Prouteau C, Colin E, Ziegler A, Winkelmann J, Jech R, Zech M.
Neurogenetics. 2021 May;22(2):137-141. doi: 10.1007/s10048-021-00637-6. Epub 2021 Mar 6.
Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment.
Roze E, Lang AE, Vidailhet M.
Curr Opin Neurol. 2018 Aug;31(4):484-490. doi: 10.1097/WCO.0000000000000577.
ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.
Cazurro-Gutiérrez A, Marcé-Grau A, Correa-Vela M, Salazar A, Vanegas MI, Macaya A, Bayés À, Pérez-Dueñas B.
Mol Neurobiol. 2021 Aug;58(8):3938-3952. doi: 10.1007/s12035-021-02391-0. Epub 2021 Apr 22.
